ROSSARISpecialty Chemicals
Rossari Biotech Ltd — Cash Flow Statement
₹378.60
-4.18%
Rossari Biotech Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -21.07 Cr | -88.03 Cr | 118.68 Cr | -8.87 Cr | — |
| Repayment Of Debt | -38.58 Cr | -11.58 Cr | 0.00 | -4.81 Cr | — |
| Issuance Of Debt | 120.72 Cr | 43.48 Cr | 65.50 Cr | 0.00 | — |
| Issuance Of Capital Stock | 5.07 Cr | 3.85 Cr | 4.21 Cr | 301.50 Cr | — |
| Capital Expenditure | -158.51 Cr | -131.28 Cr | -32.88 Cr | -38.23 Cr | — |
| End Cash Position | 44.20 Cr | 25.17 Cr | 69.20 Cr | 37.48 Cr | — |
| Beginning Cash Position | 25.17 Cr | 69.20 Cr | 37.48 Cr | 15.21 Cr | — |
| Effect Of Exchange Rate Changes | 0.38 Cr | -0.25 Cr | 0.20 Cr | 0.00 | — |
| Changes In Cash | 18.65 Cr | -43.77 Cr | 31.52 Cr | 22.27 Cr | — |
| Financing Cash Flow | 64.90 Cr | 16.18 Cr | 60.85 Cr | 291.79 Cr | — |
| Interest Paid Cff | -13.63 Cr | -15.99 Cr | -6.11 Cr | -2.15 Cr | — |
| Cash Dividends Paid | -2.77 Cr | -2.76 Cr | -2.75 Cr | -2.75 Cr | — |
| Common Stock Dividend Paid | -2.77 Cr | -2.76 Cr | -2.75 Cr | — | -2.54 Cr |
| Net Common Stock Issuance | 5.07 Cr | 3.85 Cr | 4.21 Cr | 301.50 Cr | — |
| Common Stock Issuance | 5.07 Cr | 3.85 Cr | 4.21 Cr | 301.50 Cr | — |
| Net Issuance Payments Of Debt | 82.15 Cr | 31.90 Cr | 65.50 Cr | -4.81 Cr | — |
| Net Short Term Debt Issuance | 27.25 Cr | 43.48 Cr | 20.59 Cr | -4.81 Cr | — |
| Short Term Debt Issuance | 27.25 Cr | 43.48 Cr | 20.59 Cr | — | — |
| Net Long Term Debt Issuance | 54.90 Cr | -11.58 Cr | 44.92 Cr | 0.00 | — |
| Long Term Debt Payments | -38.58 Cr | -11.58 Cr | 0.00 | 0.00 | — |
| Long Term Debt Issuance | 93.48 Cr | 0.00 | 44.92 Cr | 0.00 | — |
| Investing Cash Flow | -183.69 Cr | -103.21 Cr | -180.89 Cr | -298.88 Cr | — |
| Interest Received Cfi | 0.73 Cr | 2.63 Cr | 2.11 Cr | 4.96 Cr | — |
| Dividends Received Cfi | 0.00 | 0.07 Cr | 0.16 Cr | 70000.00 | — |
| Net Investment Purchase And Sale | -25.62 Cr | 37.60 Cr | -53.44 Cr | 87.47 Cr | — |
| Net Business Purchase And Sale | -0.32 Cr | -17.73 Cr | -98.53 Cr | -355.00 Cr | — |
| Purchase Of Business | -0.32 Cr | -17.73 Cr | -98.53 Cr | -355.00 Cr | — |
| Net PPE Purchase And Sale | -158.49 Cr | -125.79 Cr | -31.19 Cr | -36.31 Cr | — |
| Sale Of PPE | 0.02 Cr | 5.49 Cr | 1.69 Cr | 1.91 Cr | — |
| Purchase Of PPE | -158.51 Cr | -131.28 Cr | -32.88 Cr | -38.23 Cr | — |
| Operating Cash Flow | 137.44 Cr | 43.26 Cr | 151.56 Cr | 29.36 Cr | — |
| Taxes Refund Paid | -59.20 Cr | -53.88 Cr | -47.78 Cr | -50.12 Cr | — |
| Change In Working Capital | -72.98 Cr | -156.85 Cr | -27.83 Cr | -112.05 Cr | — |
| Change In Payable | 85.17 Cr | 49.63 Cr | 0.04 Cr | -21.33 Cr | — |
| Change In Inventory | -72.75 Cr | -93.85 Cr | 0.73 Cr | -48.19 Cr | — |
| Change In Receivables | -85.39 Cr | -112.63 Cr | -28.60 Cr | -42.53 Cr | — |
| Other Non Cash Items | 16.90 Cr | 16.76 Cr | 18.33 Cr | 7.65 Cr | — |
| Stock Based Compensation | 0.07 Cr | 0.69 Cr | 0.94 Cr | 1.83 Cr | — |
| Provisionand Write Offof Assets | 2.71 Cr | 3.60 Cr | 2.02 Cr | 0.89 Cr | — |
| Depreciation And Amortization | 67.07 Cr | 60.39 Cr | 62.93 Cr | 48.05 Cr | — |
| Amortization Cash Flow | 21.11 Cr | 21.15 Cr | 19.47 Cr | 12.23 Cr | — |
| Depreciation | 45.97 Cr | 39.24 Cr | 43.46 Cr | 35.83 Cr | — |
| Gain Loss On Investment Securities | -1.90 Cr | -2.52 Cr | -0.27 Cr | -1.43 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 0.26 Cr | -0.51 Cr | -0.48 Cr | 0.00 | — |
| Gain Loss On Sale Of PPE | 0.07 Cr | -1.88 Cr | -0.28 Cr | -0.64 Cr | — |
| Net Income From Continuing Operations | 185.19 Cr | 177.62 Cr | 144.22 Cr | 136.28 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | — | 2.70 Cr | — | — |
| Short Term Debt Payments | — | — | — | -4.81 Cr | -27.05 Cr |
| Net Other Investing Changes | — | — | — | 85.91 Cr | 5.81 Cr |
| Sale Of Investment | — | — | — | 1.55 Cr | 13.72 Cr |
| Gain Loss On Sale Of Business | — | — | — | 0.00 | -2.30 Cr |
| Net Other Financing Charges | — | — | — | — | 0.20 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Rossari Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.